Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

A significantly higher proportion of cases compared to controls had abnormal laboratory parameters at the time of admission, except for blood group, creatinine kinase and vitamin D. (Table 3).

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020

Case-control study · PLoS ONE · 2021

Original publication title

Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020

Sanjay P. Zodpey; Himanshu Negandhi; Vineet Kumar Kamal; Tarun Bhatnagar; Parasuraman Ganeshkumar; Arvind Athavale; Amiruddin Kadri; Amit Patel; A. Bhagyalaxmi; Deepak Khismatrao; E. Theranirajan; Getrude Banumathi; Krishna Singh; P. Parameshwari; Prasita Kshirsagar; Rita Saxena; Sanjay G. Deshpande; Kadloor Satyanand; Saurabh Hadke; Simmi Dube; Sudarshini Subramaniam; Surabhi Madan; Swapnali Kadam; Tanu Anand; Kathiresan Jeyashree; Manickam Ponnaiah; Manish Rana; Manoj V. Murhekar; DCS Reddy

© 2021 Zodpey et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

We have identified a set of parameters that can help in characterising severe COVID-19 cases in India. These parameters are part of routinely available investigations within Indian hospital settings, both public and private. Study findings have the potential to inform clinical management protocols and identify patients at high risk of severe outcomes at an early stage.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Risk factors for the development of severe COVID-19 disease and death have been widely reported across several studies. Knowledge about the determinants of severe disease and mortality in the Indian context can guide early clinical management.

Source: Background

Abstract: What methods does the paper describe?

We conducted a hospital-based case control study across nine sites in India to identify the determinants of severe and critical COVID-19 disease.

Source: Methods

Abstract: Findings

We identified age above 60 years, duration before admission >5 days, chronic kidney disease, leucocytosis, prothrombin time > 14 sec, serum ferritin >250 ng/mL, d-dimer >0.5 ng/mL, pro-calcitonin >0.15 μg/L, fibrin degradation products >5 μg/mL, C-reactive protein >5 mg/L, lactate dehydrogenase >150 U/L, interleukin-6 >25 pg/mL, NLR ≥3, and deranged liver function, renal function and serum electrolytes as significant factors associated with severe COVID-19 disease.

Source: Findings

Abstract: Interpretation

We have identified a set of parameters that can help in characterising severe COVID-19 cases in India. These parameters are part of routinely available investigations within Indian hospital settings, both public and private. Study findings have the potential to inform clinical management protocols and identify patients at high risk of severe outcomes at an early stage.

Source: Interpretation
Authors’ abstract

Background

Risk factors for the development of severe COVID-19 disease and death have been widely reported across several studies. Knowledge about the determinants of severe disease and mortality in the Indian context can guide early clinical management.

Methods

We conducted a hospital-based case control study across nine sites in India to identify the determinants of severe and critical COVID-19 disease.

Findings

We identified age above 60 years, duration before admission >5 days, chronic kidney disease, leucocytosis, prothrombin time > 14 sec, serum ferritin >250 ng/mL, d-dimer >0.5 ng/mL, pro-calcitonin >0.15 μg/L, fibrin degradation products >5 μg/mL, C-reactive protein >5 mg/L, lactate dehydrogenase >150 U/L, interleukin-6 >25 pg/mL, NLR ≥3, and deranged liver function, renal function and serum electrolytes as significant factors associated with severe COVID-19 disease.

Interpretation

We have identified a set of parameters that can help in characterising severe COVID-19 cases in India. These parameters are part of routinely available investigations within Indian hospital settings, both public and private. Study findings have the potential to inform clinical management protocols and identify patients at high risk of severe outcomes at an early stage.

Publication and source details

Original title: Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020

Sanjay P. Zodpey; Himanshu Negandhi; Vineet Kumar Kamal; Tarun Bhatnagar; Parasuraman Ganeshkumar; Arvind Athavale; Amiruddin Kadri; Amit Patel; A. Bhagyalaxmi; Deepak Khismatrao; E. Theranirajan; Getrude Banumathi; Krishna Singh; P. Parameshwari; Prasita Kshirsagar; Rita Saxena; Sanjay G. Deshpande; Kadloor Satyanand; Saurabh Hadke; Simmi Dube; Sudarshini Subramaniam; Surabhi Madan; Swapnali Kadam; Tanu Anand; Kathiresan Jeyashree; Manickam Ponnaiah; Manish Rana; Manoj V. Murhekar; DCS Reddy

PLoS ONE · 2021

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: mmurhekar@gmail.com
© 2021 Zodpey et al2021Zodpey et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://dx.doi.org/10.13039/501100001411Indian Council of Medical Research RFC No. ECD/NTF/8/2020-21/COVID dated 10.07.2020. Zodpey Sanjay P. The study was funded by the Indian Council for Medical Research under RFC No. ECD/NTF/8/2020-21/COVID dated 10.07.2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." We note that one or more of the authors are employed by a commercial company: Independent consultant Dr. DCS Reddy is an independent consultant and had neither commercial nor competing interest. He contributed to designing, technical review of the study methods and review of the manuscript. We have mentioned this in the revised manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T10:40:26.439498+00:00

DOI: 10.1371/journal.pone.0261529 · PMC8716035